Back

Frailty redefines the prognostic value of multimorbidity in heart failure

31 August 2026 (09:30 - 09:40)
Organised by: Logo
Congress Presentation Part of: Multi-organ frailty: liver fibrosis, kidney, and left atrial remodelling Comorbidities ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Viana Copeland

Chaim Sheba Medical Center, Tel Aviv Universty, Ramat Gan (Israel)

5 More presentations in this session

Presentation thumbnail
Liver fibrosis in heart failure patients is associated with adverse outcomes, signs of congestion, and ⍺v integrin-related processes: insights from BIOSTAT-CHF
Mr M. Tow (Dundee, GB)
Abstract
Presentation thumbnail
Study to evaluate the effect of balcinrenone/dapagliflozin in patients with heart failure and impaired kidney function (BalanceD-HF): background and design
Professor J. Teerlink (San Francisco, US)
Abstract
Presentation thumbnail
Performance of an artificial intelligence-based smartphone application to assess frailty in older patients with heart failure
Mr S. Tahara (Sapporo, JP)
Abstract
Presentation thumbnail
Metabolomic signature predicting ejection fraction recovery in recent-onset dilated cardiomyopathy
Doctor Y. Xie (CN)
Abstract
Presentation thumbnail
Left atrial remodeling and microstructural damage in the internal capsule in heart failure: a comparison based on left atrial maximum volume index stratification
Doctor C. Pan (Zhuhai, CN)
Abstract

Access the full session

Session thumbnail
Multi-organ frailty: liver fibrosis, kidney, and left atrial remodelling

The Event

Event poster

ESC Congress 2026

31 August 2026 09:30 CET
You may be interested in
thumbnail
Congress Presentation
Prevalence and prognostic role of different frailty deficits in patients with chronic heart failure
29 June 2021
thumbnail
Congress Presentation
Cardiometabolic disease, comorbidities and risk of death: Findings using data from large-scale electronic health records
28 August 2020
thumbnail
Congress Presentation
Influence of multi-morbidity in the effectiveness of transitional-care heart failure programmes: a population-based study with longitudinal real-world data in 77,554 patients.
23 May 2023
thumbnail
Congress Presentation
Bleeding risks with frailty and multimorbidity in patients with atrial fibrillation. A nationwide analysis of 1.4 million subjects
31 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources